vs

Side-by-side financial comparison of Stock Yards Bancorp, Inc. (SYBT) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $104.4M, roughly 1.4× Stock Yards Bancorp, Inc.). Stock Yards Bancorp, Inc. runs the higher net margin — 35.1% vs -5.3%, a 40.4% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 11.7%). Stock Yards Bancorp, Inc. produced more free cash flow last quarter ($154.0M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 11.9%).

Community Trust Bancorp is an American regional bank holding company that was founded in 1903 as Pikeville National Bank. The renamed corporation continues to have its headquarters in Pikeville, Kentucky, at the heart of Appalachia. Community Trust Bancorp operates a commercial bank, Community Trust Bank, and a trust company, Community Trust and Investment Company of Lexington.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

SYBT vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.4× larger
TOI
$142.0M
$104.4M
SYBT
Growing faster (revenue YoY)
TOI
TOI
+29.9% gap
TOI
41.6%
11.7%
SYBT
Higher net margin
SYBT
SYBT
40.4% more per $
SYBT
35.1%
-5.3%
TOI
More free cash flow
SYBT
SYBT
$151.8M more FCF
SYBT
$154.0M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
11.9%
SYBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SYBT
SYBT
TOI
TOI
Revenue
$104.4M
$142.0M
Net Profit
$36.6M
$-7.5M
Gross Margin
Operating Margin
45.9%
-4.9%
Net Margin
35.1%
-5.3%
Revenue YoY
11.7%
41.6%
Net Profit YoY
15.5%
43.0%
EPS (diluted)
$1.24
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SYBT
SYBT
TOI
TOI
Q4 25
$104.4M
$142.0M
Q3 25
$101.5M
$136.6M
Q2 25
$97.8M
$119.8M
Q1 25
$93.5M
$104.4M
Q4 24
$93.5M
$100.3M
Q3 24
$89.8M
$99.9M
Q2 24
$85.7M
$98.6M
Q1 24
$83.3M
$94.7M
Net Profit
SYBT
SYBT
TOI
TOI
Q4 25
$36.6M
$-7.5M
Q3 25
$36.2M
$-16.5M
Q2 25
$34.0M
$-17.0M
Q1 25
$33.3M
$-19.6M
Q4 24
$31.7M
$-13.2M
Q3 24
$29.4M
$-16.1M
Q2 24
$27.6M
$-15.5M
Q1 24
$25.9M
$-19.9M
Operating Margin
SYBT
SYBT
TOI
TOI
Q4 25
45.9%
-4.9%
Q3 25
45.0%
-5.9%
Q2 25
43.9%
-9.4%
Q1 25
44.5%
-9.5%
Q4 24
41.9%
-11.9%
Q3 24
41.2%
-13.9%
Q2 24
41.2%
-16.6%
Q1 24
39.5%
-19.0%
Net Margin
SYBT
SYBT
TOI
TOI
Q4 25
35.1%
-5.3%
Q3 25
35.7%
-12.1%
Q2 25
34.8%
-14.2%
Q1 25
35.6%
-18.8%
Q4 24
33.9%
-13.1%
Q3 24
32.7%
-16.1%
Q2 24
32.2%
-15.7%
Q1 24
31.1%
-21.0%
EPS (diluted)
SYBT
SYBT
TOI
TOI
Q4 25
$1.24
$-0.04
Q3 25
$1.23
$-0.14
Q2 25
$1.15
$-0.15
Q1 25
$1.13
$-0.21
Q4 24
$1.07
$-0.14
Q3 24
$1.00
$-0.18
Q2 24
$0.94
$-0.17
Q1 24
$0.88
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SYBT
SYBT
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$26.8M
Stockholders' EquityBook value
$1.1B
$-15.7M
Total Assets
$9.5B
$164.7M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SYBT
SYBT
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$9.9M
Q1 24
$29.8M
Total Debt
SYBT
SYBT
TOI
TOI
Q4 25
$26.8M
Q3 25
$26.8M
Q2 25
Q1 25
$26.8M
Q4 24
$26.8M
Q3 24
$26.8M
Q2 24
$26.8M
Q1 24
$26.8M
Stockholders' Equity
SYBT
SYBT
TOI
TOI
Q4 25
$1.1B
$-15.7M
Q3 25
$1.0B
$-12.3M
Q2 25
$1.0B
$-9.0M
Q1 25
$975.5M
$5.1M
Q4 24
$940.5M
$3.6M
Q3 24
$934.1M
$15.5M
Q2 24
$894.5M
$29.2M
Q1 24
$874.7M
$41.3M
Total Assets
SYBT
SYBT
TOI
TOI
Q4 25
$9.5B
$164.7M
Q3 25
$9.3B
$163.6M
Q2 25
$9.2B
$159.8M
Q1 25
$9.0B
$164.0M
Q4 24
$8.9B
$172.7M
Q3 24
$8.4B
$179.2M
Q2 24
$8.3B
$179.6M
Q1 24
$8.1B
$204.5M
Debt / Equity
SYBT
SYBT
TOI
TOI
Q4 25
0.02×
Q3 25
0.03×
Q2 25
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.03×
Q2 24
0.03×
Q1 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SYBT
SYBT
TOI
TOI
Operating Cash FlowLast quarter
$166.0M
$3.2M
Free Cash FlowOCF − Capex
$154.0M
$2.2M
FCF MarginFCF / Revenue
147.5%
1.5%
Capex IntensityCapex / Revenue
11.5%
0.7%
Cash ConversionOCF / Net Profit
4.54×
TTM Free Cash FlowTrailing 4 quarters
$260.5M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SYBT
SYBT
TOI
TOI
Q4 25
$166.0M
$3.2M
Q3 25
$38.2M
$-12.6M
Q2 25
$55.9M
$-10.2M
Q1 25
$19.8M
$-5.0M
Q4 24
$142.9M
$4.2M
Q3 24
$55.4M
$819.0K
Q2 24
$51.1M
$-15.7M
Q1 24
$17.4M
$-15.9M
Free Cash Flow
SYBT
SYBT
TOI
TOI
Q4 25
$154.0M
$2.2M
Q3 25
$35.2M
$-13.2M
Q2 25
$53.5M
$-11.4M
Q1 25
$17.8M
$-5.3M
Q4 24
$133.0M
$2.4M
Q3 24
$53.9M
$417.0K
Q2 24
$47.9M
$-17.5M
Q1 24
$15.6M
$-16.5M
FCF Margin
SYBT
SYBT
TOI
TOI
Q4 25
147.5%
1.5%
Q3 25
34.6%
-9.7%
Q2 25
54.7%
-9.5%
Q1 25
19.1%
-5.1%
Q4 24
142.3%
2.4%
Q3 24
60.0%
0.4%
Q2 24
55.9%
-17.7%
Q1 24
18.7%
-17.4%
Capex Intensity
SYBT
SYBT
TOI
TOI
Q4 25
11.5%
0.7%
Q3 25
3.0%
0.4%
Q2 25
2.5%
1.0%
Q1 25
2.1%
0.3%
Q4 24
10.5%
1.8%
Q3 24
1.7%
0.4%
Q2 24
3.8%
1.9%
Q1 24
2.2%
0.6%
Cash Conversion
SYBT
SYBT
TOI
TOI
Q4 25
4.54×
Q3 25
1.05×
Q2 25
1.64×
Q1 25
0.59×
Q4 24
4.51×
Q3 24
1.89×
Q2 24
1.85×
Q1 24
0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SYBT
SYBT

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons